BioSpace News Archive

Jaguar Health, Inc. announced that company management will present at the LD Micro Main Event investor conference on October 3, 2023, and at the Global Capital Network Investor Conference on October 5, 2023.

Basilea Pharmaceutica Ltd, Allschwil announced that data from the successful phase 3 study ERADICATE were published in the New England Journal of Medicine, one of the world’s leading peer-reviewed medical journals.

Turnstone Biologics Corp. announced four posters reporting preclinical data for Turnstone’s Selected TIL therapies will be presented at the 38th Annual Meeting of the Society for Immunotherapy of Cancer.

Biovica International Biovica, active in cancer monitoring, announces that the Center for Medicare & Medicaid Services has issued a preliminary CLFS payment decision for DiviTum TKa to pursue the gap-fill process during 2024.

Rockwell Medical, Inc. announced that the Company entered into a three-year product purchase agreement with Sanderling Renal Services, Inc., a full-service provider of in-center, home dialysis and renal telemedicine services focusing on patients in rural and underserved communities across the United States.

IASO Bio and Innovent Biologics, Inc. announced updated long-term follow-up data from two studies for BMCA CAR-T.

Triastek, Inc. announced the completion of a USD 20.4 million Pre-C financing round.

Merck, known as MSD outside of the United States and Canada, announced that the U.S. Food and Drug Administration has accepted for priority review a new Biologics License Application for sotatercept, Merck’s novel investigational activin signaling inhibitor, for the treatment of adult patients with pulmonary arterial hypertension .

Matinas BioPharma announces that Jerome D. Jabbour, Chief Executive Officer, will present a company overview and hold meetings with institutional investors at two upcoming investment conferences.

Bolt Biotherapeutics announced that the U.S. Food and Drug Administration granted Orphan Drug Designation for BDC-1001 for the treatment of gastric cancer, including gastroesophageal junction cancer.